El ¨primun non nocere¨ en tiempos de la pandemia por Coronavirus
Resumen
Citas
Sinha P, Matthay MA, Calfee CS. Is a "Cytokine Storm" Relevant to COVID-19? JAMA Intern Med. 2020 [published online ahead of print].
Albertson TE, Panacek EA, MacArthur RD, et al. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis. Crit Care Med. 2003; 31:419-427
López Reboiro ML, Sardiña González C, López Castro J. COVID-19 y Argumentum ad ignorantiam o «no todo vale» [COVID 19 and "Argumentum ad ignorantiam" or "not everything goes"] Rev Clin Esp. 2020 [published online ahead of print].
Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382:1787-1799.
Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. NEng J Med. 2020 [published online ahead of print].
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020 [published online ahead of print].
RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report. N Engl J Med. 2020 [published online ahead of print].
